|
Date |
ArticleType |
|
1/12/2017 |
Insights |
FDA Warns On Repeated, Lengthy Use Of General Anesthesia Drugs |
|
|
FDA Warns On Repeated, Lengthy Use Of General Anesthesia Drugs
from ADA News
The U.S. Food and Drug Administration issued a warning in December 2016 that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third trimester may affect the development of children's brains.
The FDA is requiring warnings to be added to the labels of general anesthetic and sedation drugs. The agency will also continue to monitor the use of these drugs in children and pregnant women and will update the public if additional information becomes available, according to an FDA news release.
Anesthetic and sedation drugs are necessary for infants, children and pregnant women who require surgery or other painful and stressful procedures, helping to ensure the health, safety and comfort of patients, the FDA said. Studies suggest that a single, relatively short exposure to general anesthetic and sedation drugs is unlikely to have negative effects on behavior or learning, according to the FDA. However, further research is needed to fully characterize how early life anesthetic exposure affects children's brain development.
Read full article on ADA.
|
|
|